New York State Common Retirement Fund Oric Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

$74.9 Billion
Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 45,077 shares of ORIC stock, worth $590,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,077

Previous 17,792 153.36%

Holding current value

$590,057

Previous $180,000 198.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$9.2 - $11.93 $251,021 - $325,510	27,285 Added 153.36%	45,077 $537,000
Q2 2025 Oct 08, 2025	SELL	$4.26 - $10.55 $88,156 - $218,321	-20,694 Reduced 53.77%	17,792 $180,000
Q2 2025 Aug 13, 2025	SELL	$4.26 - $10.55 $88,156 - $218,321	-20,694 Reduced 53.77%	17,792 $181,000
Q1 2025 Oct 08, 2025	BUY	$5.58 - $12.54 $124,194 - $279,102	22,257 Added 137.14%	38,486 $214,000
Q1 2025 May 01, 2025	BUY	$5.58 - $12.54 $124,194 - $279,102	22,257 Added 137.14%	38,486 $215,000

Q3 2024 Oct 08, 2025	SELL	$7.52 - $11.9 $11,753 - $18,599	-1,563 Reduced 8.78%	16,229 $166,000
Q2 2024 Oct 08, 2025	SELL	$6.63 - $12.93 $10,362 - $20,209	-1,563 Reduced 8.78%	16,229 $114,000
Q2 2024 Jul 31, 2024	SELL	$6.63 - $12.93 $188,855 - $368,311	-28,485 Reduced 63.7%	16,229 $115,000
Q1 2024 Oct 08, 2025	BUY	$8.04 - $16.03 $216,452 - $431,559	26,922 Added 151.32%	44,714 $614,000
Q1 2024 May 07, 2024	BUY	$8.04 - $16.03 $282,557 - $563,358	35,144 Added 367.23%	44,714 $615,000
Q4 2023 Oct 08, 2025	SELL	$5.41 - $9.43 $44,481 - $77,533	-8,222 Reduced 46.21%	9,570 $88,000
Q4 2023 Feb 01, 2024	SELL	$5.41 - $9.43 $33,168 - $57,815	-6,131 Reduced 39.05%	9,570 $88,000
Q3 2023 Oct 08, 2025	SELL	$6.05 - $9.28 $12,650 - $19,404	-2,091 Reduced 11.75%	15,701 $94,000
Q3 2023 Nov 07, 2023	BUY	$6.05 - $9.28 $2,426 - $3,721	401 Added 2.62%	15,701 $95,000
Q2 2023 Oct 08, 2025	SELL	$4.95 - $8.4 $12,335 - $20,932	-2,492 Reduced 14.01%	15,300 $118,000
Q2 2023 Aug 07, 2023	BUY	$4.95 - $8.4 $75,735 - $128,520	15,300 New	15,300 $119,000
Q2 2022 Aug 04, 2022	SELL	$2.7 - $7.07 $52,110 - $136,451	-19,300 Reduced 98.55%	283 $1,000
Q1 2022 May 05, 2022	BUY	$4.54 - $16.1 $118 - $418	26 Added 0.13%	19,583 $105,000
Q4 2021 Feb 02, 2022	SELL	$12.01 - $20.3 $49,781 - $84,143	-4,145 Reduced 17.49%	19,557 $287,000
Q3 2021 Nov 02, 2021	SELL	$15.9 - $25.22 $57,001 - $90,413	-3,585 Reduced 13.14%	23,702 $496,000
Q2 2021 Aug 02, 2021	BUY	$17.37 - $25.34 $100,520 - $146,642	5,787 Added 26.92%	27,287 $483,000
Q1 2021 May 11, 2021	BUY	$23.67 - $36.85 $73,377 - $114,235	3,100 Added 16.85%	21,500 $527,000
Q4 2020 Feb 08, 2021	BUY	$20.32 - $39.8 $211,328 - $413,919	10,400 Added 130.0%	18,400 $623,000
Q2 2020 Aug 07, 2020	BUY	$25.68 - $38.12 $205,440 - $304,960	8,000 New	8,000 $270,000

Others Institutions Holding ORIC

# of Institutions

157

Shares Held

105M

Call Options Held

35.1K

Put Options Held

173K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $518M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Oric Pharmaceuticals, Inc. Transaction History